Merus Announces Publication of Abstract on Zenocutuzumab in NRG1-fusion (NRG1+) Cancers at the American Society of Clinical Oncology (ASCO) 2021 Annual Meeting

NEXT STORY
Rubius Therapeutics to Present Trials in Progress Poster on the Phase 1 Clinical Trial of RTX-321 for HPV 16-Positive Cancers at the 2021 American Society of Clinical Oncology Annual Meeting
PREV STORY
Early amcenestrant data featured at ASCO support its potential to become a new endocrine backbone therapy for ER+/HER2- breast cancer
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

ContraFect to Present at JMP Securities Life Sciences Conference

YONKERS, N.Y., June 14, 2018 (GLOBE NEWSWIRE) -- ContraFect Corporation (Nasdaq:CFRX), a clinical-stage biotechnology ...

author_avatar
NASDAQ Market News

Viridian Therapeutics Reports Third Quarter 2021 Financial Results and Provides Corporate Updates

author_avatar
NASDAQ Market News

Phase 1 Data for Flotetuzumab, MacroGenics’ CD123 x CD3 DART® Molecule, Presented at 59th Annual ASH Meeting

Encouraging initial anti-leukemic activity with durable responses and acceptable tolerability observed in dose expansion ...

author_avatar
NASDAQ Market News